Biofeedback of Glucose in Non-diabetic Participants

Blood Glucose Clinical Trial

Official title:

Biofeedback of Glucose in Non-diabetic Participants

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04077203
• Other study ID #: Pro00036792
• Status: Completed
• Phase: N/A
• Start date: July 16, 2019
• Est. completion date: November 30, 2019

Study information

• Verified date: September 2019
• Source: Klick Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc.). This study utilizes wearable continuous glucose (CGM) technology, which provides personalized feedback to participants to allow them to self-monitor their own glucose levels.

Description:

The purpose of this research is to examine whether self-monitoring and biofeedback of glucose levels improves health outcomes in non-diabetic participants. All participants will receive a continuous flash glucose monitor (consisting of an adhesive patch sensor and a handheld reader device) to wear for 14 days. Participants will be randomized into one of 2 groups: those receiving biofeedback (the ability to visualize their glucose levels via the handheld device), and the control group (receiving no biofeedback because the handheld device monitor will be occluded with black tape). Participants' objective and self-report health metrics will be measured before and after the 14-day intervention. The goal is to examine whether the biofeedback condition influences any daily activities or physiological measurements compared to the control condition, as a direct result of self-monitoring glucose levels.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: November 30, 2019
• Est. primary completion date: November 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

-

Exclusion Criteria:

• Below the age of 18 years

• Diagnosis of any known chronic or acute medical disease (e.g., diabetes, cardiovascular disease, respiratory disease, influenza, pneumonia, etc.)

• Diagnosis of any known neurological disease or psychological disorder (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.)

• Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.)

• Suspected or confirmed pregnancy

• Currently breastfeeding

• Use of antibiotics in the three months prior to enrollment

• Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study

Related Conditions & MeSH terms

• Biofeedback
• Blood Glucose

Intervention

Behavioral:
• Biofeedback / No biofeedback
Biofeedback / No biofeedback

Locations

Country	Name	City	State
Canada	Klick Inc.	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Klick Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Weight in kg	Weight in kg	2 weeks
Primary	Body Mass Index (BMI)	Height in cm and weight in kg will be used to calculate BMI	2 weeks
Primary	Body fat %	Using a smart scale	2 weeks
Primary	Resting heart rate	Using a sphygmomanometer with heart rate sensor	2 weeks
Primary	Resting blood pressure (systolic and diastolic)	Using a sphygmomanometer	2 weeks
Primary	Self-reported positive and negative affect	Positive and Negative Affect Schedule (PANAS; Watson et al., 1988). The scale consists of 20 items (10 for Positive Affect; 10 for Negative Affect), with each item rated on a 5-point scale of 1 (not at all) to 5 (extremely). Items are summed for Positive affect and Negative affect, with higher scores indicating a higher level of affect in each respective scale.	2 weeks
Primary	Self-reported general health	12-Item Short-Form Health Survey (SF-12; Ware et al., 1996). The scale measures overall general self-reported physical and mental health using 12 items, on 2 to 6-point ordinal scales. The range of possible total scores is 12 to 48, with higher scores indicating better health.	2 weeks
Primary	Self-reported perceived stress	Perceived Stress Scale (Cohen et al., 1983; Cohen & Williamson, 1988). This is a 4-item scale that measures overall stress with each item evaluated on a 5-point Likert scale. The range of possible total scores is 0 to 16, with higher scores indicating more stress.	2 weeks
Primary	Self-reported sleep quality	Pittsburgh Sleep Quality Index (Buysse et al., 1989). This is a 19-item scale that measures self-reported sleep quality and sleep disturbances, comprised of open-ended questions and scaled items evaluated on a 4-point Likert scale. The range of possible total scores is 0 to 21, with higher scores indicating poorer sleep quality.	2 weeks
Primary	Self-reported general well-being	Satisfaction with Life Scale (Diener et al., 1985). This is a 5-item scale that measures overall well-being with each item evaluated on a 7-point Likert scale. The range of possible total scores is 5 to 35, with higher scores indicating higher well-being.	2 weeks